Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer.

MLA

Aurrekoetxea-Rodriguez, Iskander, et al. “Polyoxometalate Inhibition of SOX2-Mediated Tamoxifen Resistance in Breast Cancer.” Cell Communication and Signaling : CCS, vol. 22, no. 1, Sept. 2024, p. 425. EBSCOhost, https://doi.org/10.1186/s12964-024-01800-w.

APA

Aurrekoetxea-Rodriguez, I., Lee, S. Y., Rábano, M., Gris-Cárdenas, I., Gamboa-Aldecoa, V., Gorroño, I., Ramella-Gal, I., Parry, C., Kypta, R. M., Artetxe, B., Gutierrez-Zorrilla, J. M., & Vivanco, M. dM. (2024). Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer. Cell Communication and Signaling : CCS, 22(1), 425. https://doi.org/10.1186/s12964-024-01800-w

Chicago

Aurrekoetxea-Rodriguez, Iskander, So Young Lee, Miriam Rábano, Isabel Gris-Cárdenas, Virginia Gamboa-Aldecoa, Irantzu Gorroño, Isabella Ramella-Gal, et al. 2024. “Polyoxometalate Inhibition of SOX2-Mediated Tamoxifen Resistance in Breast Cancer.” Cell Communication and Signaling : CCS 22 (1): 425. doi:10.1186/s12964-024-01800-w.